{
  "id": 10657810,
  "title": "AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows",
  "url": "https://urgent.news/2026/09/29/astrazeneca-merck-novo-deals-boost-chinese-biotech-as-global-interest-10657810",
  "topic": "world",
  "section": "World",
  "published": "2026-09-29T09:00:07.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/business/china-business/article/3369187/astrazeneca-merck-novo-deals-boost-chinese-biotech-global-interest-grows"
  },
  "original_language": "en",
  "account": null,
  "summary": "Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "SCMP Business",
        "title": "AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows",
        "url": "https://urgent.news/2026/09/29/astrazeneca-merck-novo-deals-boost-chinese-biotech-as-global-interest",
        "published": "2026-09-29T09:00:07.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}